Intercure Ltd.
Produces and distributes GMP-certified, pharmaceutical-grade medical cannabis products.
INCR | TA
Overview
Corporate Details
- ISIN(s):
- IL0011063760
- LEI:
- 549300KI5ESXF8F5GP06
- Country:
- Israel
- Address:
- 11 USSISHKIN STREET, 3844346 HADERA
- Website:
- https://www.intercure.co
- Sector:
- Manufacturing
Description
Intercure Ltd. is a company focused on the production and distribution of pharmaceutical-grade medical cannabis and cannabis-based products. Operating primarily through its wholly-owned subsidiary, Canndoc Ltd., the company is a licensed producer of Good Manufacturing Practice (GMP) certified medical cannabis. Intercure's strategy involves international expansion through strategic partnerships, such as producing and distributing established brands like Cookies in European markets, and through acquisitions to access premium technologies and brands. The company leverages its EU-GMP certified manufacturing facilities to supply its products for medical use across its operational territories.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-04-25 11:10 |
e Informs That An Application To Approve a Class Action Against 26 Cannabis Com…
|
English | 35.9 KB | ||
| 2023-04-20 17:44 |
InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Ge…
|
English | 147.0 KB | ||
| 2023-04-20 17:44 |
InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Ge…
|
English | 35.9 KB | ||
| 2023-04-04 01:37 |
InterCure Announces Reschedules 2022 Full Year Results Conference Call
|
English | 91.8 KB | ||
| 2023-04-04 01:37 |
InterCure Announces Reschedules 2022 Full Year Results Conference Call
|
English | 35.9 KB | ||
| 2023-04-01 12:45 |
Fourth Quarter and Fiscal Year End 2022 Results
|
English | 6.7 MB | ||
| 2023-04-01 12:45 |
Fourth Quarter and Fiscal Year End 2022 Results
|
English | 35.9 KB | ||
| 2023-02-14 16:43 |
Intercure Files Lawsuit Against Cann Pharmacuticals to Recover Funds Following …
|
English | 85.4 KB | ||
| 2023-02-14 16:43 |
Intercure Files Lawsuit Against Cann Pharmacuticals to Recover Funds Following …
|
English | 36.0 KB | ||
| 2023-02-01 16:52 |
Termination of its Acquisition Agreement with Cann Pharmaceutical (dba Better)
|
English | 111.1 KB | ||
| 2023-02-01 16:52 |
Termination of its Acquisition Agreement with Cann Pharmaceutical (dba Better)
|
English | 35.9 KB | ||
| 2022-12-19 16:39 |
InterCure Announces Exclusive International Partnership Agreement with Award Wi…
|
English | 161.7 KB | ||
| 2022-12-19 16:39 |
InterCure Announces Exclusive International Partnership Agreement with Award Wi…
|
English | 35.9 KB | ||
| 2022-12-08 17:46 |
Participate in Cowen 5th Annual Cannabis Conference
|
English | 103.9 KB | ||
| 2022-12-08 17:46 |
Participate in Cowen 5th Annual Cannabis Conference
|
English | 35.9 KB |
Automate Your Workflow. Get a real-time feed of all Intercure Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Intercure Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Intercure Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
